Jingrong Jean Cui, Chief Scientific Officer at Turning Point Therapeutics, Inc. (TPTX), sold 109,900 shares at $58.38 ($6.0M) on 2020-01-10, disclosed to the SEC on 2020-01-14.
Open-market sale of $6.0M TPTX by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $54.00 | 300 | $16K | 0.3% |
| 2 | $55.75 | 400 | $22K | 0.4% |
| 3 | $56.79 | 4,250 | $241K | 4.0% |
| 4 | $56.79 | 4,250 | $241K | 4.0% |
| 5 | $57.95 | 10,525 | $610K | 10.1% |
| 6 | $57.95 | 10,525 |
| $610K |
| 10.1% |
| 7 | $58.38 | 1,291 | $75K | 1.3% |
| 8 | $58.38 | 1,291 | $75K | 1.3% |
| 9 | $58.83 | 1,734 | $102K | 1.7% |
| 10 | $58.83 | 1,734 | $102K | 1.7% |
| 11 | $52.49 | 7,906 | $415K | 6.9% |
| 12 | $52.49 | 7,906 | $415K | 6.9% |
| 13 | $53.11 | 10,194 | $541K | 9.0% |
| 14 | $53.11 | 10,194 | $541K | 9.0% |
| 15 | $54.21 | 400 | $22K | 0.4% |
| 16 | $52.44 | 3,390 | $178K | 3.0% |
| 17 | $52.44 | 3,390 | $178K | 3.0% |
| 18 | $53.30 | 5,009 | $267K | 4.4% |
| 19 | $53.30 | 5,009 | $267K | 4.4% |
| 20 | $54.06 | 10,101 | $546K | 9.1% |
| 21 | $54.06 | 10,101 | $546K | 9.1% |
| Total | $54.70 avg | 109,900 | $6.0M | 100% |
| Filing → |
| TPTX | SELL | 2020-05-21 | $1.2M | — | Filing → |
| TPTX | SELL | 2020-05-12 | $1.2M | — | Filing → |
| TPTX | SELL | 2020-05-07 | $5.8M | — | Filing → |